510(k) K181077
K181077 is an FDA 510(k) premarket notification submitted by Actigraph for the device "ActiGraph CentrePoint Insight Watch". The FDA issued a decision of Substantially Equivalent on May 24, 2018. The device falls under product code LEL (Device, Sleep Assessment), a Class II device regulated under 21 CFR 882.5050. Actigraph has at least 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 24, 2018
- Date Received
- April 24, 2018
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Device, Sleep Assessment
- Device Class
- Class II
- Regulation Number
- 882.5050
- Review Panel
- NE
- Submission Type